LPCAT3 and metabolic dysfunction-associated steatohepatitis: Furthermore, the latest research unveiled the pivotal role of LPCAT3 in NASH progression, particularly through its influence on membrane phospholipid composition and mitochondrial homeostasis (Tian et al., 2024).